{
    "nctId": "NCT04628806",
    "briefTitle": "Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells",
    "officialTitle": "Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells in Patients With Advanced or Metastatic Tumors.",
    "overallStatus": "UNKNOWN",
    "conditions": "Melanoma Stage IV, Sarcoma, Squamous Cell Carcinoma, Pancreatic Cancer Stage IV, Prostate Cancer, Breast Cancer Stage IV",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 120,
    "primaryOutcomeMeasure": "Radiographic response to initial treatment",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Metastatic malignant melanoma (stage IV)\n* Metastatic or unresectable pancreatic adenocarcinoma (stage III or IV)\n* Metastatic breast cancer\n* Metastatic sarcoma\n* Metastatic squamous cell carcinoma of the cervix uteri, head and neck region, vulva, anus or penis\n* hormone-refractory prostate cancer\n\nExclusion Criteria:\n\n* psychiatric disorders that impede adequate informed consent",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}